Has Sanjeet Rangarajan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $113,484 in general payments to Sanjeet Rangarajan, MD across 213 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sanjeet Rangarajan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sanjeet Rangarajan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sanjeet Rangarajan, MD

Otolaryngology · Cleveland, OHNPI 1649568395

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $72,994 of the $113,484 with a category attached, or 64.3%. 23 manufacturers reported payments, led by Intersect ENT, Inc. at 48.0% of the total. Reporting peaked in 2021 at $27,774 and has fallen 81.2% since, to $5,216 in 2025. Among otolaryngology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$113,484in general payments, 2019–2025

Across 213 payments — averaging $532.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intersect ENT, Inc.$54K
Medtronic$45K
KARL Storz Endoscopy-america$10K
Gyrus ACMI, Inc.$1K
Stryker$777
Smith+Nephew$219
plus $2K from 17 others

What the payments were for

Consulting fees$14,68813%
Speaking & faculty fees$72,99464%
Travel & lodging$18,05816%
Food & beverage$7,7457%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intersect ENT, Inc.	55	$54,441
Medtronic(2 entities)	117	$44,940
KARL Storz Endoscopy-america	6	$10,180
Gyrus ACMI, Inc.	1	$1,063
Stryker	7	$777
Smith+Nephew	2	$219
Integra Lifesciences Corporation	3	$208
Sanofi	3	$182
Optinose US, Inc.	1	$163
Regeneron Healthcare Solutions, Inc.	2	$151
Aroa Biosurgery Incorporated	1	$141
Regeneron	1	$140
Baxter Healthcare	1	$138
Neurent Medical Limited	1	$127
Axogen	1	$121
Inspire Medical Systems, Inc.	1	$115
Acclarent, Inc	1	$110
Aerin Medical Inc.	2	$64
Kls-martin L.p.	2	$61
Pentax Of America, Inc.	2	$58
Zimmer Biomet	1	$57
Organogenesis Inc.	1	$16
GSK	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TELE PACK$9,127
FUSION$7,637
SINUVA$6,213
PROPEL$6,185
STEALTHSTATION S8 PLATFORM$1,301
IMAGE 1,H3-ZA,HEAD,ZOOM,ACLAV,50/60HZ,CE$710
STRAIGHTSHOT$561
DUPIXENT$273
VSP SYSTEM, VSP CRANIAL$273
SCOPIS ENT$254
NUVENT$250
Xhance$163
Halo$146
Coblation$146
TULA$146
XPRESS LOPROFILE$144
CLEARVISION II SET$140
TISSEEL$138
STROBO VIDEO,MIC,FOOTSWITCH LOYAL KT$130
NEUROMARK System$127

How this compares

$113,484 in reported general payments places this provider in the 95th percentile of 380 otolaryngology providers in Ohio.

See all otolaryngology providers in Ohio →

Medicare billing

Part B allowed, 2024

$89,894

Medicare patients

126

Services billed

520

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Azelastine Hcl	60	$1,867
Ipratropium Bromide	45	$831
Fluticasone Propionate	21	$279
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	16	$74

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Cleveland

Raj SindwaniCleveland$598K
Mark MehleCleveland$403K
Troy WoodardCleveland$392K
Rod RezaeeCleveland$54K
Michael BenningerCleveland$32K
Cameron WickCleveland$21K
Kyra OsborneCleveland$14K
Daniel AlamCleveland$11K
Mohamad ChaabanCleveland$10K
Kenneth RodriguezCleveland$8K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →